drugset / Trial / NCT02037191
The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Alopecia areata (AA) is an auto immune disorder. Treatment of severe types remains difficult with a rate of hair regrowth which is lower than 10%. This RCT will assess the safety and efficacy of methotrexate alone or associated with low doses of prednisone versus placebo in the treatment of severe types of AA.
Timeline
- Start
- 2014-02
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 25 mg | — |